Method for inhibiting the release of bioactive interleukin-1 (IL-1)

摘要

A method for the treating an individual afflicted with a disease condition mediated by IL-1 bioactivity is disclosed. The method comprises administering an effective amount of the NOS inhibitor, aminoguanidine, to an individual.